Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001628280-24-011693
Filing Date
2024-03-18
Accepted
2024-03-18 17:05:32
Documents
1
Effectiveness Date
2024-03-18

Document Format Files

Seq Description Document Type Size
1 15-12G a20240318form15-12g.htm 15-12G 12034
  Complete submission text file 0001628280-24-011693.txt   13310
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 000-21088 | Film No.: 24759931
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)